(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS IL2RA (INTERLEUKIN 2 RECEPTOR ALPHA SUBUNIT, IL-2RA, TAC, P55, CD25)], HOMO SAPIENS MONOCLONAL ANTIBODY CONJUGATED TO THE PYRROLOBENZODIAZEPINE (PBD) DIMER SCX; GAMMA1 HEAVY CHAIN (1-445) [HOMO SAPIENS VH (IGHV1- 69*02 (94.90%) -(IGHD) -IGHJ4*01) [8.8.8] (1-115) -HOMO SAPIENS IGHG1*03, G1M3, NG1M1 (CH1 R120 (212) (116- 213), HINGE (214-228), CH2 (229-338), CH3 E12 (354), M14 (356) (339-443), CHS (444-445)) (116-445)], (218- 214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') [HOMO SAPIENS V-KAPPA (IGKV3-20*01 (99.00%) -IGKJ4*01) [6.3.9] (1'-107') -HOMO SAPIENS IGKC*01, KM3 A45.1 (153), V101 (191) (108'-214')]; DIMER (224-224'':227-227'')- BISDISULFIDE; CONJUGATED, ON AN AVERAGE OF 2 CYSTEINES, TO THE PYRROLOBENZODIAZEPINE (PBD) DIMER SCX, VIA A CLEAVABLE (VALINE-ALANINE DIPEPTIDE AS CATHEPSINE B CLEAVAGE SITE) MALEIMIDE TYPE LINKER CONTAINING A SPACER PEG (N=8). RECOMMENDED INN: LIST 79(WHO)
CAMIDANLUMABUM TESIRINUM(INN)